Case ID: 164

Publication date: 18 Nov, 2015

Consensus grade: Carcinoma in situ (CIS)

User Diagnosis Difficulty Comment
Pathologist 1 Carcinoma in situ (CIS) Typical
Pathologist 2 Carcinoma in situ (CIS) Typical
Pathologist 3 Carcinoma in situ (CIS) Typical
Pathologist 4 Carcinoma in situ (CIS) Typical
Pathologist 5 Carcinoma in situ (CIS) Typical
Pathologist 6 Carcinoma in situ (CIS) Typical
Pathologist 7 Carcinoma in situ (CIS) Typical

Hard to judge IHCH without knowing antibody...

Pathologist 8 Carcinoma in situ (CIS) Typical
Pathologist 9 Carcinoma in situ (CIS) Typical
Pathologist 10 Carcinoma in situ (CIS) Typical
Pathologist 11 Carcinoma in situ (CIS) Typical
Pathologist 12 Carcinoma in situ (CIS) Borderline higher
Pathologist 13 Carcinoma in situ (CIS) Typical
Pathologist 14 Carcinoma in situ (CIS) Typical
Pathologist 15 Carcinoma in situ (CIS) Typical

No specific comment.

Pathologist 16 Carcinoma in situ (CIS) Bordering on lower
Pathologist 17 Carcinoma in situ (CIS) Typical
Pathologist 18 Carcinoma in situ (CIS) Typical
Pathologist 19 Carcinoma in situ (CIS) Typical
Pathologist 20 Carcinoma in situ (CIS) Typical
Pathologist 21 Atypia/dysplasia Bordering on higher
Pathologist 22 Carcinoma in situ (CIS) Typical


Case description (by case creator):

This case illustrates urothelial carcinoma in-situ (CIS). URO3 immunohistochemistry is shown (CK20 = red, p53 = brown, CD44 = blue). The diagnosis is based primarily on morphology and immunohistochemistry cannot separate CIS from dysplasia. Adjacent normal urothelium is shown for comparison.